艾普斯坦-巴尔病毒感染的鼻癌治疗药物:coprotein目标和临床影响
Jacqueline Kar Kei Mark1, Aik-Hong Teh2, Beow Keat Yap3
1School of Pharmaceutical Sciences, Universiti Sains Malaysia, 11800, Gelugor, Penang, Malaysia.
Medical oncology (Northwood, London, England)
|January 31, 2025
概括
准爱斯坦-巴尔病毒 (EBV) 上蛋白如EBNA1,LMP1和LMP2为治疗鼻癌 (NPC) 提供了一个有前途的新策略. 对这些病毒蛋白的抑制剂的研究表明,在EBV阳性NPC患者中改善结局的潜力.
科学领域:
- 在瘤学瘤学.
- 病毒学 病毒学
- 药物发现 药物发现 药物发现
背景情况:
- 鼻癌 (NPC) 是一种与爱斯坦-巴尔病毒 (EBV) 密切相关的上皮癌.
- 目前的放射治疗和化疗等治疗方法的疗效有限,特别是对于复发性或转移性NPC.
- 高复发率和治疗耐药性强调了对新型治疗方法的需求.
研究的目的:
- 审查近期药物发现的进展,在NPC治疗中准EBVcoproteins.
- 要突出针对EBNA1,LMP1和LMP2.2特定功能区域的抑制剂.
- 讨论这些抑制剂的分子机制和治疗潜力.
主要方法:
- 关于EBV上蛋白抑制剂的最近研究的文献综述.
- 对针对EBNA1,LMP1和LMP2的药物发现工作的分析.
- 对已识别的抑制剂的临床前和临床数据的评估.
主要成果:
- 识别针对EBNA1,LMP1和LMP2的关键功能区域的新型抑制剂.
- 阐明了这些抑制剂的作用背后的分子机制.
- 在EBV阳性NPC模型中证明临床前和潜在的临床疗效.
结论:
- 向EBVcoproteins是NPC的一种有前途的治疗策略.
- 抑制EBNA1,LMP1和LMP2的抑制剂显示出改善治疗结果的潜力.
- 进一步开发这些向疗法可能会显著有利于NPC患者.
相关概念视频
Tumor Immunotherapy
464
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
464
Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Cancer Vaccines
329
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
329
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Cytotoxic T Cells-mediated Immune Response
833
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
833


